Wedmont Private Capital’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
RG
CDDEC
AAMU
AIM
AV
MIF
ZIC
Wedmont Private Capital's AZN Position: Q2 2026 in Review
Wedmont Private Capital reduced its AstraZeneca (AZN) stake by 11% in Q2 2026, selling an estimated $120K and leaving 5,202 shares worth $893K. The position accounts for 0.02% of the portfolio, ranked #379.
Wedmont Private Capital first reported a position in AZN in Q1 2022 and has held it in 18 quarters since. The position peaked at $1.19M in Q1 2026. 443 funds tracked by Wall St. Rank hold AZN as of Q2 2026.
- Wedmont Private Capital held 5,202 shares of AstraZeneca worth $893K as of Q2 2026.
- Wedmont Private Capital sold 636 AstraZeneca shares in Q2 2026, an estimated $120K.
- AstraZeneca made up 0.02% of Wedmont Private Capital's portfolio in Q2 2026, its #379 holding.
- Wedmont Private Capital first reported a position in AstraZeneca in Q1 2022 and has held it in 18 quarters since.
- Wedmont Private Capital's AstraZeneca position peaked at $1.19M in Q1 2026.
- 443 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.
Based on Wedmont Private Capital's 13F filing for Q2 2026, filed 13 Jul 2026.